Default company panoramic image
7e7624f3 0236 4d42 bb26 7bbdcc515c00

Quiecor Heart Treatment Centers of America, Inc.

Quiecor has developed the only known therapy which will stop, reverse, and prevent cardiovascular disease, the world's #1 killer.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Crown Point, IN, USA
  • Currency USD
  • Founded December 2011
  • Employees 7
  • Website

Company Summary

This ground-breaking therapy for heart disease will be used in clinics worldwide to provide a new way of addressing the cause of heart disease, reducing the need for stents, by-pass surgery and angioplasty. The U.S. market is approaching $500 billion annually with a disease market of 500 million people worldwide. Treatment accounts for nearly $1 of every $6 spent. Quiecor Therapy provides a proven way to treat the cause of heart disease.


  • Default avatar
    Daniel Juhnkie
    Vice President Operations

    Internet and Systems Engineer; Application executive with ATT&T, Nesessitas, Presidio, Consultant in sales and installation of technology.

  • Default avatar
    Frank C. Clark
    Chairman & Co-CEO

    Frank’s medical industry experience spans six companies as president and chairman and eight Boards of Directors. His background includes executive management at Johnson & Johnson where he served as Vice President and Director of J & J’s flagship company Ethicon. As J & J expanded, Frank’s executive talents were employed to nurture newly acquired technologies, such as Stimulation Technology and Ethicon Medical Products.

  • Default avatar
    William H. Reeves, PhD
    Founder, President & Co-CEO

    Dr. Reeves holds twenty-five granted and provisional patents on medical and medically related products many of which have become standards of practice. He has started 3 medical companies and sold one of his patents for $5 million.

  • Default avatar
    William R. Davis, MD
    Vice President & Medical Director

    Dr. Davis is the former Asst. Professor of Medicine at Case Western Reserve College of Medicine. He left the field of interventional Cardiology when his mother died of "sudden death," the number one symptom of Vascular Disease. Dr. Davis has become a leading luminary in calcium scoring and preventive cardiology.

  • Default avatar
    William Breslin, CPA
    Vice President & CFO

    Bill is a Sarbanes Oxley qualified CPA; he wasa senior audit manager Price Waterhouse Coopers; Senior Financial officer Washington Post, Hertz mountain and Zondervan Publishing.

  • Default avatar
    Robert K. Hunter
    Vice President of Business Development

    President of Medical Products Sales, Inc. a multistate distributor of orthopedic products. Bob has become an outstanding consultant in operating room technologies for Dyonics, Encision, and Micro surgical techniques.

  • Default avatar
    Richard Lind
    Vice President of Marketing and Communications

    Former marketing /communications manager with Chryler, 3M, International Harvester, Bunker-Ramo and Coca-Cola.
    Organized an independent advertising firm serving clients AON, IBM Europe, Walmart SunTrust Bank and Georiga Tech.,


  • Default avatar
    Posinelli Corporate, SEC, Wiliam Graham, PhD Esq. Intellectual property
    Default avatar
    Auditor/Accountant: Aheran & Jasco, CPA; Compliance: J.W. Reeves, MBA